As an Associate Director of Statistical Programming at Arcutis Biotherapeutics, Inc., I lead the programming and quality control activities of phase II and III studies for innovative dermatological treatments. With more than eighteen years of experience in the pharmaceutical industry, I have developed and validated analysis datasets, tables, figures, and listings, following company standards and regulatory guidelines. I have extensive experience in the CDISC SDTM and ADaM standards, ISS and ISE analysis, P21 validation and development and review of Reviewers guide. I have also contributed to the successful submission of many phase III studies to the FDA, PMDA and other regulatory agencies providing the required documents and files for the electronic submission. I have worked in many TAs including Oncology, CNS, Infectious diseases, Dermatology, Ophthalmology, Cardiovascular.In addition to my technical skills, I have also demonstrated my leadership and collaboration abilities by managing and mentoring a team of programmers, coordinating timelines and milestones, and providing training and support for the department applications and tools. I am passionate about applying my mathematical and computational background to the field of clinical research, and I am always eager to learn new methods and technologies to enhance the quality and efficiency of the statistical analysis. My goal is to deliver reliable and robust results that can support the development and approval of new therapies for patients with unmet medical needs.